InSphero ranked #2 Startup of the Year in Switzerland
Zurich, Switzerland, November 5, 2012 – InSphero AG, experts in three-dimensional microtissue technology, is proud to announce that the company has been ranked number 2 startup in the TOP 100 Swiss Startups 2012 list and recognized for its global success and customer base of top pharma companies.
Around 100 experts from the Swiss business startup scene have ranked InSphero the number 2 startup (all categories) in Switzerland and, again, as in 2011, the number 1 startup in the biotech space. The jury recognized the global success of InSphero's 3D microtissue technology for more predictive compound testing and the fact that InSphero currently counts 7 of the top 10 global pharmaceutical and cosmetics companies as customers.
Dr. Jan Lichtenberg, Chief Executive Officer and Co-founder of InSphero, says: "At InSphero, we are very proud of the accomplishment and appreciate the recognition accorded to the company and its dedicated employees. This is a great success for us, given the strengths of other startup companies in Switzerland. At the same time, this high ranking is a clear indication that business veterans, investors, and startup experts recognize the global awareness that InSphero has generated for 3D cell culture and its sustainably growing business."
